SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of $17.00...
Hence then, the article about immune mediated disease therapeutics developer attovia therapeutics debuts on nasdaq was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq )
Also on site :
- After a decade of failed bills and three years of resignations, Washington finally discovers it cares about AI safety
- Dakota Johnson on Being in Taylor Swift’s ‘Patient Zero’ Music Video: ‘We Respect Each Other’s Creative Minds’
- ’60s Folk Singer Was Discovered by David Bowie at 15 and Produced by Jimmy Page at 16—Where Is She Now?